美高梅中国(02282.HK)首三季经调整EBITDA盈转亏 蚀17.4亿元
美高梅中国(02282.HK)公布,控股股东美高梅国际酒店集团公布今年第三季业绩,其中包括根据美国公认会计原则编制及呈列的美高梅中国财务资料,截至今年9月底季度,总收益为3.63亿元,按年下跌93.71%,经调整EBITDA录亏损7.31亿元,去年同期为盈利15.48亿元。
至於今年首三季,美高梅中国总收益为27.34亿元,按年下跌83.99%,当中澳门美高梅及美狮美高梅收益分别下跌83.7%及84.37%;经调整EBITDA为亏损17.39亿元,去年同期盈利46.25亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.